Section archive

Gardasil

Drug

FDA: Gardasil approved to prevent anal cancer

The approval covers ages 9 to 26 and rests on a trial in men who reported sex with men, where Gardasil prevented HPV 16- and 18-related anal intraepithelial neoplasia in 78% of participants. The FDA assumed the same efficacy applies to women.

Drug

Gardasil gets FDA okay to fight anal cancer

The FDA expanded Gardasil's approved use to prevent anal cancer and precancerous lesions caused by HPV types 6, 11, 16 and 18. The American Cancer Society estimates 5,300 anal cancer diagnoses a year in the US, and HPV is associated with about 90% of cases.

Dec 24, 2010

Drug

Cool Ads Aren't Helping Gardasil and Cervarix Vaccines

Research presented to the American Association for Cancer Research finds women declining the heavily advertised HPV vaccines, with a third not returning after the first of three shots. The piece questions the $359.25 price and cites 56 US girls' deaths reported to the CDC after vaccination.

Dec 10, 2010

Drug

Gardasil for Boys Deemed Fiscally Imprudent

FDA analysis so far suggests vaccinating boys against HPV would not be cost-effective, since girls are already urged to be immunized. The researchers assumed 75 percent of young women will eventually be vaccinated; a lower figure would prompt a re-evaluation.

Oct 10, 2009

4 stories